Back to Search

STEPHANIE JONES, MD

MD

Interventional Pain Medicine Physician

NPI: 1003073941IndividualAccepts Medicare

Specialties, Licenses & Credentials

Anesthesiology Physician

Anesthesiology

Code: 207L00000X

N0143(TX)MD434208(PA)
Interventional Pain Medicine PhysicianPrimary

Pain Medicine — Interventional Pain Medicine

Code: 208VP0014X

N0143(TX)
Pain Medicine (Anesthesiology) Physician

Anesthesiology — Pain Medicine

Code: 207LP2900X

N0143(TX)

CMS Specialties

PrimaryANESTHESIOLOGY

Additional

PAIN MANAGEMENT

Education

BAYLOR COLLEGE OF MEDICINE

Class of 2004

Research & Publications (20)

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.
PMID 19204201·J Clin Oncol·2009
3-trial
Exemestane as adjuvant treatment of early breast cancer: intergroup exemestane study/tamoxifen exemestane adjuvant multicenter trials.
PMID 16595025·Clin Breast Cancer·2006
4-observational
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
PMID 17135639·J Clin Oncol·2006
3-trial
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer.
PMID 16110015·J Clin Oncol·2005
3-trial
Effectiveness and tolerability of fulvestrant in postmenopausal women with hormone receptor-positive breast cancer.
PMID 15865850·Clin Breast Cancer·2005
4-observational
Fulvestrant: an estrogen receptor antagonist that downregulates the estrogen receptor.
PMID 14613022·Semin Oncol·2003
6-review
Pelvic pain and history of previous pelvic surgery.
PMID 16278726·Proc (Bayl Univ Med Cent)·2003
8-other
The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers.
PMID 12538178·Anesth Analg·2003
3-trial
Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node-negative breast cancer.
PMID 12123539·Clin Breast Cancer·2002
3-trial
A new estrogen receptor antagonist--an overview of available data.
PMID 12353819·Breast Cancer Res Treat·2002
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
5323 HARRY HINES BLVD
DALLAS, TX 75390

Quick Facts

NPI
1003073941
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
4
Locations
1
Years in Practice
22
Publications
20

Are you this provider?

Claim Your Profile